Login / Signup

Nonalcoholic fatty liver disease burden: Australia, 2019-2030.

Leon A AdamsStuart Keith RobertsSimone I StrasserSuzanne E MahadyElizabeth PowellChris EstesHomie RazaviJacob George
Published in: Journal of gastroenterology and hepatology (2020)
Restraining growth of the obese and diabetic populations, along with potential therapeutic options, will be essential for mitigating disease burden.
Keyphrases
  • type diabetes
  • adipose tissue
  • metabolic syndrome
  • weight loss
  • risk factors
  • obese patients
  • bariatric surgery
  • liver fibrosis